Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.

    ... arms. There was no difference in neutrophil engraftment failure (2.5 vs. 2.33 %; p = 0.959), acute ... by Cy-ATG in terms of reducing RRT levels without increasing engraftment failure. (ClinicalTrials.gov number: NCT01145976). ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia

    ... or variable number tandem repeat any MSC engraftment in patient marrow 30, 90 or 180 days after infusions. ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

    ... HSCT regimen for SAA results in durable engraftment with a low incidence of chronic GVHD. ...

    Research Article last updated 07/20/2018 - 5:14pm.

  4. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia

    ... previous immunotherapy. The median durations for myeloid engraftment in the haplo- and MUD cohorts were 14 (range, 10 to 21) and 13 ...

    Research Article last updated 06/13/2018 - 2:28pm.

  5. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... the efficacy and safety of sitagliptin in enhancing engraftment following umbilical cord blood transplantation (recovery of ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.

  6. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... the efficacy and safety of sitagliptin in enhancing engraftment following umbilical cord blood transplantation (recovery of ...

    Clinical Trial last updated 06/03/2016 - 2:54pm.

  7. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... Have identified a back-up cell source in case of engraftment failure. The source can be autologous, related or unrelated. ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  8. New study on SCT therapy for SAA, MDS patients

    ... Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Imrpove Transplant Outcome, is a Phase ½ trial in which the primary endpoint is prompt and durable cord engraftment. "The study, announced today, represents a significant ...

    Article last updated 08/22/2017 - 9:41am.

  9. Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results

    ... out of 44 patients, who died early before hematopoietic engraftment , were not assessed. Evaluable patients (97.6%; 40/41) achieved ... sustained full donor chimerism. The median time for myeloid engraftment was 12 days (range 8-21 days) and for platelet engraftment ...

    Research Article last updated 02/01/2017 - 12:30pm.

  10. Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.

    ... ×, P<1e-6). Of all the outcome parameters evaluated ( engraftment , rejection/graft failure, GvHD, TRM, OS), high F-araA AUC ...

    Research Article last updated 05/22/2017 - 10:32am.